Ftse Mib
38.655,09
0,08%
DAX
22.551,43
0,12%
S&P 500
5.954,50
1,59%
NASDAQ
18.847,28
1,63%
Bitcoin
84.970,18
0,71%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vincerx Inc (VINC) Vincerx Inc (VINC) Notizie

Vincerx Inc

VINC
0,80
-0,46 (-36,51%)
01 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/2/202522:10EDGAR2Form 8-K - Current report
28/2/202522:05GLOBEVincerx Pharma Announces Termination of Reverse Merger Term..
18/2/202522:03EDGAR2Form 8-K - Current report
12/2/202514:30EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
06/2/202522:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/2/202522:05EDGAR2Form 8-K - Current report
29/1/202522:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/1/202514:00GLOBEVincerx Pharma, Inc. and Oqory, Inc. Highlight Promising..
24/1/202522:08EDGAR2Form S-3 - Registration statement under Securities Act of..
23/1/202522:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/1/202522:10EDGAR2Form 8-K - Current report
23/1/202522:05GLOBEVincerx Pharma, Inc. Announces Reverse Stock Split
21/1/202522:31EDGAR2Form 8-K - Current report
21/1/202522:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/1/202523:11EDGAR2Form 8-K - Current report
27/12/202422:13EDGAR2Form 8-K - Current report
27/12/202422:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/12/202422:05GLOBEVincerx Pharma Enters into a Binding Term Sheet for a..
10/12/202422:02EDGAR2Form DEF 14A - Other definitive proxy statements
06/12/202422:04EDGAR2Form 8-K - Current report
04/12/202412:45GLOBEVincerx Pharma to Implement Cost-Controls to Support..
25/11/202423:05EDGAR2Form 8-K - Current report
12/11/202415:04EDGAR2Form 8-K - Current report
12/11/202415:00GLOBEVincerx Pharma Reports Third Quarter 2024 Financial Results
05/11/202415:15EDGAR2Form PRE 14A - Other preliminary proxy statements
07/10/202422:05GLOBEVincerx Reports Positive Initial Clinical Data from Ongoing..
30/9/202412:57EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
10/9/202422:02EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
19/8/202422:01EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
16/8/202422:01EDGAR2Form 8-K - Current report
15/8/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:06EDGAR2Form SC TO-I - Tender offer statement by Issuer
08/8/202422:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:37EDGAR2Form 8-K - Current report
08/8/202422:30GLOBEVincerx Pharma Reports Second Quarter 2024 Financial Results
02/8/202422:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/7/202422:45EDGAR2Form DEF 14A - Other definitive proxy statements
30/5/202403:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:06EDGAR2Form 8-K - Current report
14/5/202422:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:21EDGAR2Form 8-K - Current report
14/5/202422:15GLOBEVincerx Pharma Reports First Quarter 2024 Financial Results..
26/4/202406:27GLOBEVincerx Pharma Announces Pricing of Underwritten Public..
25/4/202422:01GLOBEVincerx Pharma Announces Proposed Underwritten Public..
Apertura: 1,15 Min: 1,06 Max: 1,20
Chiusura: 1,26

La tua Cronologia

NASDAQ
VINC
Vincerx
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci